U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. Copycat medications, produced through a ...
CEO Sabrina Martucci Johnson announced the company's intent to make its proprietary Sildenafil Cream formulation available by prescription through a 503B-registered outsourcing facility in Q4 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results